SplitJul 24, 2026, 05:31 PM
ENvue Medical to Vote on Reverse Stock Split (1-for-2 to 1-for-50)
AI Summary
ENvue Medical, Inc. announced a Special Meeting of Stockholders on August 14, 2026, to vote on a reverse stock split proposal. The company received a delisting notice from Nasdaq for failing to meet the $1.00 minimum bid price requirement. The proposed reverse stock split, ranging from 1-for-2 to 1-for-50, aims to cure this deficiency and maintain its Nasdaq listing. The Board of Directors unanimously recommends approval of the proposal.
Key Highlights
- Special Meeting of Stockholders on August 14, 2026, at 10:00 a.m. ET.
- Record Date for voting is July 20, 2026.
- Proposal for a reverse stock split in the range of 1-for-2 to 1-for-50.
- Aims to regain compliance with Nasdaq's $1.00 minimum bid price requirement.
- Company received Nasdaq delisting notice on July 10, 2026.
- Previously effected 1-for-10 reverse split on August 12, 2025, and 1-for-11 on March 13, 2025.
- Board recommends voting 'FOR' the Reverse Stock Split Proposal.
Price Impact
More from FEED